Salvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects.
This study was conducted to examine the SM-induced anti-osteoporotic effect and its possible mechanisms with various doses of SM.
Methods: We studied Sprague-Dawley female rats aged 12 weeks, divided into six groups: shamoperated control (SHAM), ovariectomized (OVX), and OVX rats supplemented with SM (1, 3, 10 and 30 mg/kg) orally for 8 weeks. At the end of the experiment, blood samples were collected and biochemistry analysis was performed.
Specimens from both tibia and liver were processed for light microscopic examination. DEXA and mu-CT analyses of the tibia were also performed.
Results: SM treatment significantly ameliorated the decrease in BMD and trabecular bone mass according to DEXA and trabecular bone architecture analysis of trabecular bone structural parameters by mu-CT scanning.
In serum biochemical analysis, SM decreased the released TRAP-5b, an osteoclast activation marker and oxidative stress parameters including MDA and NO induced by OVX.
Conclusions: The preventive effect of SM was presumably due to its anti-oxidative stress partly via modulation of osteoclast maturation and number. In current study, SM appears to be a promising osteoporosis therapeutic natural product.
Author: Yan CuiBidur BhandaryAnu MarahattaGeum-Hwa LeeBo LiDo-Sung KimSoo-Wan ChaeHyung-Ryong KimHan-Jung Chae
source: 7thspace
Characterization of Salvia Miltiorrhiza ethanol extract as an anti-osteoporotic agent
Monday, November 28, 2011 | Ethanol Industry News | 0 comments »
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment